三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LABU 三倍做多标普生物-Direxion

盘后交易 02-26 18:57:23 EST

173.70

-3.17

-1.79%

盘后172.15

-1.55-0.89%

18:47 EST

最高174.61	最低163.00	成交量74.13万
今开174.61	昨收176.87	日振幅6.56%
总市值5.86亿	流通市值5.86亿	总股本337.45万
成交额1.25亿	换手率21.97%	流通股本337.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":173.7,"timestamp":1772139600000,"preClose":176.87,"halted":0,"volume":741331,"hourTrading":{"tag":"盘后","latestPrice":172.15,"preClose":173.7,"latestTime":"18:47 EST","volume":751,"amount":129502.5151,"timestamp":1772149641609,"change":-1.55,"changeRate":-0.008923,"amplitude":0.017271},"delay":0,"changeRate":-0.017922768134788353,"floatShares":3374486,"shares":3374486,"eps":0,"marketStatus":"盘后交易","change":-3.17,"latestTime":"02-26 18:57:23 EST","open":174.61,"high":174.61,"low":163,"amount":124961666.79083,"amplitude":0.065641,"askPrice":172.8,"askSize":200,"bidPrice":171,"bidSize":5,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772154000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":176.87,"sharesOutstanding":3224486,"nav":176.296,"aum":568463849.72,"dividendRate":0.007746,"bidAskSpread":0.001847,"preHourTrading":{"tag":"盘前","latestPrice":175,"preClose":176.87,"latestTime":"09:29 EST","volume":1251,"amount":220470.2352,"timestamp":1772116170007,"change":-1.87,"changeRate":-0.010573,"amplitude":0.011421},"postHourTrading":{"tag":"盘后","latestPrice":172.15,"preClose":173.7,"latestTime":"18:47 EST","volume":751,"amount":129502.5151,"timestamp":1772149641609,"change":-1.55,"changeRate":-0.008923,"amplitude":0.017271},"volumeRatio":1.300709,"impliedVol":0.8917,"impliedVolPercentile":0.5498},"requestUrl":"/m/hq/s/LABU","defaultTab":"news","newsList":[{"id":"2614805640","title":"优宁维：公司参与投资的股权投资基金投向覆盖医疗健康等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2614805640","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614805640?lang=zh_cn&edition=full","pubTime":"2026-02-25 21:15","pubTimestamp":1772025300,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：公司有涉足布局投资脑机接口等未来产业吗？优宁维（301166.SZ）2月25日在投资者互动平台表示，公司参与投资的股权投资基金投向覆盖医疗健康等领域，投资者可关注相关基金的投资进展。（文章来源：每日经济新闻）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-25/doc-inhnzvzh5036942.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-25/doc-inhnzvzh5036942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","BK4581","XLV","301166","159760","XBI","BK4588","LABU","BK4585"],"gpt_icon":0},{"id":"2614720806","title":"Cathie Wood：AI 将在医疗保健领域实现最深远的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2614720806","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614720806?lang=zh_cn&edition=full","pubTime":"2026-02-25 09:08","pubTimestamp":1771981691,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，Cathie Wood 在 X 平台发文表示，根据 ARKInvest 的研究，AI 最深远的应用领域将是医疗保健。放松管制正在加速医疗保健领域的这一变革。评估药物疗效的科学已取得巨大进步，研发项目通过作用机制、生物标志物效应和中间终点等多维度收集证据，这些从机制数据到真实世界证据的验证性证据可替代第二项关键试验。\n\n历史上在罕见病和肿瘤领域已有较大监管灵活性，预计此次从两项降至一项的改变将在心血管和呼吸等常见疾病领域产生最大影响，每个项目有望节省高达 3.5 亿美元成本并缩短数年研发周期。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2247690","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","ARKQ","BK4581","BK4544","BK4585","XLV","XBI","LABU","BK4588","ARKK"],"gpt_icon":0},{"id":"2614743797","title":"Edesa Biotech, Inc.盘中异动 股价大涨5.41%报0.948美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614743797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614743797?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:32","pubTimestamp":1771943546,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日22时32分，Edesa Biotech, Inc.股票出现波动，股价大幅拉升5.41%。Edesa Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Biorestorative Therapies, Inc.、Larimar Therapeutics, Inc.、Palvella Therapeutics, Inc.涨幅较大，Cardio Diagnostics Holdings Inc.、Silo Pharma, Inc.、Biorestorative Therapies, Inc.较为活跃，换手率分别为211.73%、164.09%、147.96%，振幅较大的相关个股有Maia Biotechnology, Inc.、Edesa Biotech, Inc.、Vir Biotechnology, Inc.，振幅分别为100.00%、12.24%、10.63%。Edesa Biotech, Inc.公司简介：Edesa Biotech Inc 是一家专注于炎症和免疫相关疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224223226a4c36b9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224223226a4c36b9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDSA","BK4588","BK4139","BK4585","LABU"],"gpt_icon":0},{"id":"2613795952","title":"创胜集团-B(06628)将出席奥本海默第36届年度医疗健康生命科学大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2613795952","media":"智通财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613795952?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:34","pubTimestamp":1771922044,"startTime":"0","endTime":"0","summary":"自2025 年10月上次更新以来，本公司已续期银行融资人民币7700万元，并获得新融资人民币1500万元，且正与另外三家金融机构商讨进一步信贷额度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","XLV","159760","06628","BK4585","XBI","BK4581","LABU","BK4588"],"gpt_icon":0},{"id":"2613196917","title":"AMN医疗保健服务公司盘中异动 早盘急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613196917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613196917?lang=zh_cn&edition=full","pubTime":"2026-02-23 22:33","pubTimestamp":1771857234,"startTime":"0","endTime":"0","summary":"北京时间2026年02月23日22时33分，AMN医疗保健服务公司股票出现波动，股价急速拉升5.10%。AMN医疗保健服务公司股票所在的医疗设施行业中，整体涨幅为0.96%。其相关个股中，Enhabit, Inc.、AMN医疗保健服务公司、Innovage Holding Corp.涨幅较大，Enhabit, Inc.、Newgenivf Group Limited、AMN医疗保健服务公司较为活跃，换手率分别为4.62%、1.89%、0.37%，振幅较大的相关个股有AMN医疗保健服务公司、Lifestance Health Group, Inc.、The Oncology Institute, Inc.，振幅分别为5.25%、3.22%、3.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223223355a716335c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223223355a716335c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","AMN","XBI","BK4196","LABU","XLV","BK4585","BK4581"],"gpt_icon":0},{"id":"2613297648","title":"Purple Biotech Ltd盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613297648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613297648?lang=zh_cn&edition=full","pubTime":"2026-02-21 01:37","pubTimestamp":1771609027,"startTime":"0","endTime":"0","summary":"北京时间2026年02月21日01时37分，Purple Biotech Ltd股票出现异动，股价快速跳水5.31%。截至发稿，该股报0.523美元/股，成交量4.0033万股，换手率0.44%，振幅7.07%。Purple Biotech Ltd股票所在的生物技术行业中，整体跌幅为0.08%。Purple Biotech Ltd公司简介：Purple Biotech Ltd 是一家临床阶段公司，专注于推进一流疗法以克服肿瘤免疫逃避和耐药性，并为癌症患者创造治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022101370797a696a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022101370797a696a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PPBT","BK4007","BK4585","BK4588","LABU"],"gpt_icon":0},{"id":"2612266839","title":"生物医药企业Polaryx直接上市：市值1.26亿美元 9个月亏749万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612266839","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612266839?lang=zh_cn&edition=full","pubTime":"2026-02-20 18:42","pubTimestamp":1771584176,"startTime":"0","endTime":"0","summary":"生物医药企业Polaryx Therapeutics（股票代码：“PLYX”）日前在美国纳斯达克直接上市，截至目前，公司市值为1.26亿美元。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260220/6390720976347670688886744.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260220/6390720976347670688886744.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32697/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["BK4588","161726","BK4585","LABU","399441"],"gpt_icon":0},{"id":"2612234896","title":"美国OTC市场Nkgen Biotech, Inc.盘中异动 股价大跌14.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612234896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612234896?lang=zh_cn&edition=full","pubTime":"2026-02-20 04:34","pubTimestamp":1771533240,"startTime":"0","endTime":"0","summary":"北京时间2026年02月20日04时34分，美国OTC市场Nkgen Biotech, Inc.股票出现异动，股价急速下挫14.29%。美国OTC市场Nkgen Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。美国OTC市场Nkgen Biotech, Inc.公司简介：NKGen Biotech Inc 是一家生物技术公司，开发基于活化 NK 细胞的神经退行性和肿瘤疾病细胞疗法。SNK 细胞可以大量生产并冷冻保存，同时保持高水平的细胞毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220043400a4b4419e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220043400a4b4419e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","NKGN","BK4139","LABU"],"gpt_icon":0},{"id":"2612688286","title":"美国医疗保险优势计划增长再度放缓","url":"https://stock-news.laohu8.com/highlight/detail?id=2612688286","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612688286?lang=zh_cn&edition=full","pubTime":"2026-02-19 23:20","pubTimestamp":1771514400,"startTime":"0","endTime":"0","summary":"美国医疗保险优势计划参保人数同比增长放缓至约3%，在定价和医疗成本压力下，休曼纳（Humana）增加了会员，而联合健康集团和CVS Health旗下的安泰则流失了参保人。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-19/doc-inhnkpth0848747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","XLV","BK4581","BK4585","XBI","BK4588"],"gpt_icon":0},{"id":"2612347876","title":"美国FDA局长抱怨：美国在早期药物研发方面正落后于中国","url":"https://stock-news.laohu8.com/highlight/detail?id=2612347876","media":"观察者网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612347876?lang=zh_cn&edition=full","pubTime":"2026-02-19 08:12","pubTimestamp":1771459949,"startTime":"0","endTime":"0","summary":"美国食品药品管理局局长马蒂·马卡里日前警告称，在早期药物研发方面，美国正落后于中国，并呼吁进行改革，以简化新疗法临床试验的启动流程。当地时间2月18日，在接受美国消费者新闻与商业频道采访时，马卡里特别指出了导致美国在早期药物试验方面落后的三大瓶颈。据悉，这正吸引国际大型制药商将更多研发资金投入中国，在美国政客中引发忧虑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8qrf75YHOQH","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["BK4548","LU0477156953.USD","LU0154245756.USD","LU0320765489.SGD","CBRE","IND","SG9999004253.SGD","LU1201861249.SGD","BK4585","LU1496350171.SGD","BK4079","LU0130517989.USD","LU1496350502.SGD","LABU","LU0980610538.SGD","BK4588","LU0070302665.USD","SG9999001077.SGD","LU0648001328.SGD","LU0208291251.USD","LU0130102774.USD","LU0154245673.USD"],"gpt_icon":0},{"id":"2612425413","title":"Pharmacyte  Biotech, Inc.盘中异动 早盘股价大涨5.02%报0.684美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612425413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612425413?lang=zh_cn&edition=full","pubTime":"2026-02-19 00:06","pubTimestamp":1771430793,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日00时06分，Pharmacyte  Biotech, Inc.股票出现波动，股价快速拉升5.02%。截至发稿，该股报0.684美元/股，成交量2.9323万股，换手率0.29%，振幅4.05%。Pharmacyte  Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Pharmacyte  Biotech, Inc.公司简介：PharmaCyte Biotech Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219000633a707a8fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219000633a707a8fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMCB","BK4585","LABU","BK4588"],"gpt_icon":0},{"id":"2611118298","title":"大兴机场临空区，国际生物医药园（二期）冲出正负零","url":"https://stock-news.laohu8.com/highlight/detail?id=2611118298","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611118298?lang=zh_cn&edition=full","pubTime":"2026-02-14 12:39","pubTimestamp":1771043940,"startTime":"0","endTime":"0","summary":"新京报讯 据“这里是大兴”微信公众号消息，大兴机场综保区内，随着最后一方混凝土浇筑完成，国际生物医药园 项目顺利冲出正负零建设节点，迈入主体结构施工新阶段。作为临空区投运的首个生物医药标厂项目，综保区国际生物医药园（一期）自2023年投入运营以来，凭借综保区特有的保税研发、保税生产等政策优势，已初步形成产业集聚。","market":"us","thumbnail":"https://media.bjnews.com.cn/cover/2026/02/14/5686710861528375996.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/02/14/5686710861528375996.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1771041749129846.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1771041749129846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["399441","161726","BK4588","LABU","BK4585"],"gpt_icon":0},{"id":"2611130059","title":"2026年中国生物科技授权交易将迎爆发式增长，有望创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2611130059","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611130059?lang=zh_cn&edition=full","pubTime":"2026-02-13 17:52","pubTimestamp":1770976320,"startTime":"0","endTime":"0","summary":"全球制药企业在专利到期前纷纷削减成本，正加大力度寻找中国研发的创新候选药物，行业分析师预计，今年相关授权交易规模将飙升至历史新高。　　中国大陆是这一浪潮的绝对核心。　　“未来 18–24 个月，这类对外授权交易总额有望再翻一番。全球药企正高度聚焦在中国寻找下一代创新药管线，并探索多种交易结构。”　　2026 年至今已宣布38 笔对外授权交易；2025 年全年为186 笔。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-13/doc-inhmskfk5919270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4585","LABU","159837"],"gpt_icon":0},{"id":"2611990950","title":"今年已有30家医药企业拟赴港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2611990950","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611990950?lang=zh_cn&edition=full","pubTime":"2026-02-13 00:17","pubTimestamp":1770913020,"startTime":"0","endTime":"0","summary":"据北京商报记者不完全统计，今年开年40余日，已有约30家医药企业递表港交所。　　药企扎堆赴港，“创新”成为关键词。上述30家企业中，13家为带有特殊标识“B”的未盈利的创新药、创新医疗器械企业。此外，还有信立泰、海特生物两股已于年内官宣正在筹划赴港上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-13/doc-inhmqrvv9450966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","SINA","BK4585","BK1574","BK4588","06978","BK1515","LABU","HEXmain","09939"],"gpt_icon":0},{"id":"2610692400","title":"四方光电：2026年1月，公司以自有资金受让出资额并增资的方式取得苏州畅合生物科技有限公司57.14%的股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2610692400","media":"证券日报 ","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610692400?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:38","pubTimestamp":1770903480,"startTime":"0","endTime":"0","summary":"证券日报网2月12日讯 ，四方光电在接受调研者提问时表示，2026年1月，公司以自有资金受让出资额并增资的方式取得苏州畅合生物科技有限公司57.14%的股权。本次投资是基于公司战略发展规划所作出的审慎决策，旨在拓展公司在生物安全监测领域的业务布局。此次战略整合畅合生物，双方将在产品技术开发、运营生产和销售渠道等方面深度融合，将四方光电的传感器产业领域向更加高端的生物安全检测仪器领域拓展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-12/doc-inhmqmpz6698250.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-12/doc-inhmqmpz6698250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159837","BK0214","688665","LABU","BK4588","BK4585"],"gpt_icon":0},{"id":"2610946007","title":"AMN医疗保健服务公司盘中异动 临近收盘大幅下挫5.03%报19.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610946007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610946007?lang=zh_cn&edition=full","pubTime":"2026-02-12 04:39","pubTimestamp":1770842399,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日04时39分，AMN医疗保健服务公司股票出现波动，股价快速跳水5.03%。截至发稿，该股报19.34美元/股，成交量66.875万股，换手率1.74%，振幅5.88%。AMN医疗保健服务公司股票所在的医疗设施行业中，整体涨幅为5.58%。AMN医疗保健服务公司公司简介：AMN Healthcare Services Inc 在美国提供医疗保健劳动力解决方案和人员配备服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021204400097a5d710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021204400097a5d710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","XBI","BK4588","BK4585","XLV","BK4581","AMN","LABU"],"gpt_icon":0},{"id":"2610955288","title":"Humana公布季度亏损扩大，预计2026年盈利将下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2610955288","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610955288?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:29","pubTimestamp":1770820140,"startTime":"0","endTime":"0","summary":"Humana公司公布第四季度亏损扩大，原因是医疗成本持续上升，并表示由于其联邦医疗保险计划的质量评级下降，预计 2026 年盈利将大幅下滑。　　该公司报告亏损 10.1 亿美元，合每股亏损 6.61 美元；去年同期亏损 8.62 亿美元，合每股亏损 5.76 美元。　　Humana预计，2026 年个人联邦医疗保险优选计划会员数量将增长约 25%，“这得益于公司以客户为导向的福利策略带来的新增销售与留存率提升，以及客户服务模式的优化”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"696b8a17e4fa7092b272f2259db5b868","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-11/doc-inhmnhqz7462659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","XBI","BK4588","BK4581","LABU","BK4585"],"gpt_icon":0},{"id":"2610934545","title":"Healthcare Services第四季度EPS为0.44美元 高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2610934545","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610934545?lang=zh_cn&edition=full","pubTime":"2026-02-11 20:01","pubTimestamp":1770811298,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["HCAR","XLV","BK4588","BK4585","LABU","XBI","BK4581"],"gpt_icon":0},{"id":"2610780989","title":"百龙创园(605016.SH)拟设立百龙创园(南京)生物科技有限公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2610780989","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610780989?lang=zh_cn&edition=full","pubTime":"2026-02-11 15:40","pubTimestamp":1770795623,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百龙创园(605016.SH)发布公告，公司基于发展战略规划及经营发展需要，以自有资金1000万元，在南京投资设立全资子公司百龙创园(南京)生物科技有限公司(简称“南京百龙”)，公司直接持有南京百龙100%的股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0226","605016","LABU","BK4585","159837","BK4588"],"gpt_icon":0},{"id":"2610937278","title":"AMN医疗保健服务公司盘中异动 下午盘股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610937278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610937278?lang=zh_cn&edition=full","pubTime":"2026-02-11 02:35","pubTimestamp":1770748555,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日02时35分，AMN医疗保健服务公司股票出现波动，股价大幅拉升5.27%。AMN医疗保健服务公司股票所在的医疗设施行业中，整体涨幅为0.31%。其相关个股中，Park Dental Partners, Inc.、Docgo Inc.、AMN医疗保健服务公司涨幅较大，Newgenivf Group Limited、Agilon Health, Inc.、P3 Health Partners Inc.较为活跃，换手率分别为19.38%、2.69%、2.62%，振幅较大的相关个股有The Oncology Institute Inc C/Wts 、Agilon Health, Inc.、P3 Health Partners Inc.，振幅分别为22.92%、16.71%、15.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102355597a5aed8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102355597a5aed8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","BK4581","LABU","XBI","BK4585","BK4588","XLV","AMN"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.061},{"period":"1month","weight":-0.0128},{"period":"3month","weight":0.0687},{"period":"6month","weight":1.5504},{"period":"1year","weight":1.1428},{"period":"ytd","weight":0.1097}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.020883},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.00725},{"month":3,"riseRate":0.2,"avgChangeRate":-0.145647},{"month":4,"riseRate":0.4,"avgChangeRate":-0.008819},{"month":5,"riseRate":0.5,"avgChangeRate":0.005207},{"month":6,"riseRate":0.727273,"avgChangeRate":0.127955},{"month":7,"riseRate":0.636364,"avgChangeRate":0.054287},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.004065},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.0652},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.047038},{"month":11,"riseRate":0.818182,"avgChangeRate":0.199161},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.032237}],"exchange":"ARCA","name":"三倍做多标普生物-Direxion","nameEN":"Direxion Daily S&P Biotech Bull 3x Shares"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三倍做多标普生物-Direxion(LABU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三倍做多标普生物-Direxion,LABU,三倍做多标普生物-Direxion股票,三倍做多标普生物-Direxion股票老虎,三倍做多标普生物-Direxion股票老虎国际,三倍做多标普生物-Direxion行情,三倍做多标普生物-Direxion股票行情,三倍做多标普生物-Direxion股价,三倍做多标普生物-Direxion股市,三倍做多标普生物-Direxion股票价格,三倍做多标普生物-Direxion股票交易,三倍做多标普生物-Direxion股票购买,三倍做多标普生物-Direxion股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三倍做多标普生物-Direxion(LABU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}